Neurogenesis in the mammalian CNS is predominantly a prenatal event. Two exceptions are the hippocampal formation and olfactory bulb, where the majority of granule cells are produced during early postnatal life and continue to be produced well into adulthood (Kaplan and Hinds, 1977; Bayer, 1982; Bayer et al., 1982; Gueneau et al., 1982; Stanfield and Trite, 1988; Altman and Bayer, 1990) . Relatively little is known about the mechanisms that regulate neurogenesis in brain. However, two proteins have recently been identified that appear to play pivotal roles in cell cycle regulation within all cell types examined thus far. RB, the retinoblastoma susceptibility gene, is one of a growing number of tumor suppressor genes. The protein product of the RB gene is a nuclear phosphoprotein that can bind and sequester transcription factors involved in cell cycle progression (Bagchi et al., 1991; Bandara and La Thangue, 199 1; Bandara et al., 1991; Chellappan et al., 199 1; Defeo-Jones et al., 1991; Kaelin et al., 199 1) and whose absence or inactivation has been correlated with the release from cell cycle inhibition (Goodrich et al., 1991; Hara et al., 1991; Hatzfeld et al., 1991) and the development of a variety of neoplasms (Abramson et al., 1984; Friend et al., 1987; Harbour et al., 1988; Lee et al., 1988; T'Ang et al., 1988; Shew et al., 1989; Bookstein et al., 1990; Hensel et al., 1990; Horowitz et al., 1990; Ishikawa et al., 199 1) . In addition, recent studies have shown that transgenic mice that lack a functional RB gene are nonviable and exhibit extensive neuronal degeneration during middle embryonic stages (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) suggesting a critical role for RB during CNS development. The activity of RB is determined, at least in part, by its phosphorylation state with the underphosphorylated form associated with cell cycle inhibition (Buchkovich et al., 1989; Chen et al., 1989; Ludlow et al., 1990; Mihara et al., 1990; Goodrich et al., 1991) . One kinase that has been implicated in the phosphorylation and inactivation of RB is the cell cycle-related kinase cdc2. Cdc2 (the p34cdc2 kinase) was originally described as the catalytic subunit of mitosis-promoting factor in frog oocytes as well as being essential to the initiation of mitosis in yeast (for reviews, see Dunphy and Newport, 1988; Lee and Nurse, 1988; Draetta, 1990; Nurse, 1990) . Cdc2 in association with various cyclins has since been shown to play an essential role in the initiation of mitosis in a wide variety of eukaryotic cells from yeast to humans, as well as an essential role in the G, to S transition in yeast (Dunphy and Newport, 1988; Lee and Nurse, 1988; Draetta, 1990; Nurse, 1990) . Like RB, the phosphorylation state of cdc2 oscillates during the cell cycle, with the hypophosphorylated form associated with the initiation of mitosis and commitment to divide (Draetta and Beach, 1988; Nurse, 1990 ). Cdc2 has also been shown to bind with and to catalyze the phosphorylation of RB (Lees et al., 1991; Lin et al., 1991) . Studies indicate that both RB and cdc2 are expressed in brain (Bemards et al., 1989) ; however, there have been no studies localizing their expression to specific cell types or correlating their expression in brain with cellular proliferation. In the present study we have combined immunocytochemical techniques with autoradiographic detection of 3H-thymidine (3H-Thy) incorporation in order to characterize the expression of these cell cycle-related proteins as cells proliferate and differentiate into functional neurons. In this report we have focused on proliferating cells in the adult hippocampal formation and olfactory bulb since many of these cells are neuroblasts that have been guidelines. Animals received a single injection of )H-Thy (4 pCi/gm body weight, s.c.). At 2 hr (n = 4), 12 hr (n = 4), 24 hr (n = 4), 3 d (n = 3), 1 week (n = 4), and 4 weeks (n = 4) postinjection, animals were anesthetized with pentobarbital (50 mg/kg) and perfused with saline followed by 4% paraformaldehyde in 50 mM PBS. Brains were removed, posttixed with paraformaldehyde for 4 hr, and then placed in a 10% sucrose/PBS solution at 4°C overnight. Thirty-micrometer frozen sections were cut in the coronal plane through the hippocampal formation and cerebellum and in the sagittal plane through the olfactory bulb and anterior lateral ventricle. Adjacent series were processed for immunocytochemical detection of either RB (monoclonal antibody purchased from Pharmingen Pharmaceuticals and used at 4 &ml), mammalian cdc2 [rabbit anti-cdc2 (G6) raised against the C-terminal region of cdc2 generously provided by Dr. D. Beach and diluted 1: IOOO], neuronspecific enolase (NSE, rabbit anti-NSE purchased from Cambridge Pharmaceuticals and diluted 1:3000), or Fos and Fos-related antigens [rabbit anti-Fos raised against amino acids 127-l 52 (m-peptide) generously provided by Dr. M. Iadarolla and diluted 1:2000]. All antibodies were diluted in 50 mM PBS with 0.05% Triton X-100, 1% BSA, and 1% normal serum. Sections were incubated with primary antibody solution for 2-3 d at 4°C. To control for nonspecific binding, primary antibody either was omitted or was preadsorbed with 4 &ml of the appropriate antigen (a fragment of recombinant human RB, provided by Dr. Sibylle Mittnadt; NSE, Cambridge Pharmaceuticals; or m-peptide, provided by Dr. T. Curran). Antigen corresponding to the C-terminal region of cdc2 was not available. However, the cdc2 antibody used has been well characterized (Draetta and Beach, 1988) , appears to be highly specific for cdc2, and does not recognize several cdc2-related kinases. Sections were then rinsed with PBS and incubated with the appropriate biotinylated secondary antibody (rat-adsorbed horse anti-mouse for the detection of RB and goat anti-rabbit for the detection of cdc2, NSE, or Fos) for 1 hr at room temperature. Visualization of antibody binding was accomplished using an avidin-biotin-HRP system with 3-3'-diaminobenzidine (0.5 mg/ml) and H,O, (0.0 1%) added to the final reaction solution. Sections were mounted onto gelatin-coated slides and then dipped in Kodak NTB-3 radiographic emulsion. Autoradiograms were Pentylenetetrazol-inducedseizureactivity. An additional eight animals received a single injection of pentylenetetrazol(50 mg/kg, i.p.) either 1 week (n = 4) or 4 weeks (n = 4) after receiving 'H-Thy. Animals that displayed intense tonic/clonic seizure activity (two at 1 week and two at 4 weeks) were anesthetized and perfused 3 hr later and then processed for immunocytochemical detection of Fos-like immunoreactivity (Fos-IR) and autoradiography as described above. Data analysis. Twelve equally spaced coronal sections through anterior and posterior regions of the hippocampal formation and two midsagittal sections through the olfactory bulb and anterior lateral ventricle were analyzed'from each animal. The total numbers of 'H-Thyincorporating cells double labeled with RB-, cdc2-, NSE-, or Fos-IR in the subgranular region of the dentate gyrus, hippocampal CA4, and olfactory bulb were quantified. Note that, with respect to RB, only cells with intense nuclear RB-like staining (see Fig. 1B ) were quantified. Since proliferating cells migrate rostrally within the periventricular region of the bulb, thymidine-labeled cells at different levels along the migratory path and within discrete cell layers including the internal granular layer, mitral cell layer, and glomerular layer were analyzed separately. This allowed us to correlate the detection of immunoreactivity with cellular migration and neuronal differentiation in the bulb.
Results
RB-IR was detected in neurons and glial cells throughout the brain, which is consistent with the relatively high levels of RB mRNA that have been detected (Bemards et al., 1989) . Large regional differences in staining density were observed, with the most intense staining consistently detected in hippocampal CA 1 pyramidal cells, pyriform cortex, and cerebellar Purkinje cells (Fig. 1 ). Significant staining was also observed in many other areas including the other hippocampal cell layers (Fig. lA) , the striatum, thalamus, hypothalamus, cerebral cortex, and amygdala (not shown). Indeed, few cells appeared to be completely devoid of RB-IR. All RB staining could be abolished by preadsorption of the antibody with a fragment of recombinant human RB (not shown). RB-IR was predominantly nuclear, although cytoplasmic staining was also observed, particularly in CA1 pyramidal cells, where nuclear staining was quite intense (Fig.  1C) . Intensely stained RB-IR cells were also detected in the subgranular region of the dentate gyrus and along the subependymal layer of the anterior lateral ventricle extending into the olfactory bulb. In the dentate gyrus, these cells were organized in small, tightly packed groups or islands (Fig. 1B) from which individual cells would migrate into the granule cell layer and develop into mature granule cells (see below). CdQ-IR was also detected in brain, though not as ubiquitously as RB-IR. Cdc2-positive cells were detected in the hilus of the dentate gyrus (Fig. 2B) as well as in cerebellar Purkinje cells (Fig. 2C ) and olfactory bulb mitral cells (not shown). As with RB, cdc2-IR cells were also detected in the subgranular region of the dentate gyrus (see below) and along the subependymal layer extending from the anterior lateral ventricle into the olfactory bulb ( Fig. 2A) . Note that Cdc2-IR staining was often both nuclear and cytoplasmic (see Fig. 2B ,C), although cells with only nuclear or cytoplasmic staining were also observed.
By combining immunocytochemistry with autoradiography, we were able to correlate RB and cdc2 expression with cellular proliferation and to analyze changes in immunoreactivity as cells matured and differentiated into functioning neurons. As illustrated in Figure 1 B, small groups (islands) of intense RB-IR cells were detected in the subgranular region of the dentate gyrus. Approximately three to five of these groups (three or four cells/group) were detected per section, and the distribution of these cells closely matched the distribution of neuronal precursor cells that have previously been described (Kaplan and Hinds, 1977; Bayer, 1982; Bayer et al., 1982; Guaneau et al., 1982; Altman and Bayer, 1990) . When animals were killed 2 hr after receiving thymidine, 80.5% ofthe thymidine-incorporatingcells detected in the subgranular region of the dentate gyrus displayed intense nuclear RB-IR staining (see Table 1 , Fig. 3A ). In contrast, only 32.5% were immunoreactive for cdc2 (Fig. 2B ) and very few (0.3%) were immunoreactive for NSE (see Fig. 3C ). In many cases the cdc2-IR staining was cytoplasmic and cdc2-IR processes were occasionally observed. By 12 hr postinjection the percentage of 'H-Thy-labeled cells in the subgranular region showing intense RB-IR had decreased to 58.8% while the percentage double-labeled for cdc2-IR increased to 43.3% (Table  1) . We assume that by this time the majority of 3H-Thy-labeled cells had exited S-phase and progressed into G,-or M-phase. This is supported by the finding that 12 hr later (24 hr postinjection) the number of 'H-Thy-labeled cells detected in the subgranular region had doubled (from 107.8 k 23.3 to 234.0 f 63.1 cells/l 2 sections/animal), indicating that the labeled cells detected 2 hr postinjection had indeed divided. In addition, the percentage of 3H-Thy-labeled cells at this time showing intense RB-IR had decreased further to 40.5% while the percentage double labeled for cdQ-IR remained essentially unchanged (Table 1).
As the recently divided cells matured, their expression of RB-, cdc2-, and NSE-IR continued to change (see Table 1 ). Within 1 week postinjection, only 1.6% and 1.7% of 3H-Thy-labeled cells in the dentate gyrus showed intense RB-IR or cdc2-IR whereas 14.3% now stained for NSE. In addition, many )HThy-labeled cells displaying less RB-IR than adjacent granule cells were now observed (not shown). By 4 weeks postinjection, very few 3H-Thy-labeled cells with intense RB-or cdQ-IR were detected, although many cells showed weak RB-IR staining comparable to surrounding granule cells. In addition, 82.0% of the thymidine-labeled cells were now immunoreactive for NSE (Fig. 30) demonstrating that the majority of these cells had indeed differentiated into neurons.
To determine if the newly differentiated neurons were functional, we examined the expression of Fos-IR in response to pentylenetetrazole-induced seizure activity. In the absence of induced seizures, very few (< 1%) 'H-Thy-labeled cells in the dentate gyrus were immunoreactive for Fos-IR at any of the six time points examined. However, within 3 hr following seizure activity, an induction of Fos-IR within 2 1 .O% (at 1 week postthymidine injection) and 8 1.3% (at 4 weeks post-thymidine injection) of the 3H-Thy-labeled cells detected in the granule cell layer was observed (Fig. 3E,F) , suggesting that these cells had formed functional connections.
Thymidine-labeled cells were also consistently detected in the subependymal region of the olfactory bulb. As in previous reports (Altman, 1969; Rosselli-Austin and Altman, 1979; Bayer, 1983; Kishi, 1987) , precursor cells originated in the subependymal layer of the anterior lateral ventricle. The proliferating cells then migrated along the subependymal layer (the migratory route; see Fig. 4A ) into the bulb where they entered the internal granular layer and differentiated into neurons and glia.
When animals were killed 2 hr after thymidine injection, the majority (74.1%) of 3H-Thy-labeled cells showed strong nuclear RB-IR staining and were located predominantly in the sube- pendymal layer near the anterior lateral ventricle (see Figs. 4, 54) . In contrast, only 30.4% were immunoreactive for cdc2 and none were immunoreactive for NSE (Table 2) . Changes observed over time were comparable to those observed for 3H-Thy-labeled cells detected in the subgranular region of the dentate gyrus. The percentage of 'H-Thy-labeled cells showing intense RB-IR decreased to 41.2% and to 23.2% at 12 hr and 24 hr postinjection, respectively, by which time the number of 3H-As time passed and the cells migrated into the bulb, the perThy-labeled cells detected had more than doubled (from 140.6 centage of 3H-Thy-labeled cells showing RB-and cdQ-IR continued to decrease to where, by 1 week postinjection, only 1.5% and 1.6% were double labeled (see Table 2 , Fig. 5B ). By this -t 6.7 to 340.1 + 24.3 cells/2 sections/animal), indicating that time the majority of thymidine-incorporating cells were located the previously labeled cells had completed mitosis. During this time the percentage of 3H-Thy-labeled cells immunoreactive for cdc2 also decreased to 21.0%. Note that little change was observed in the position of the cells along the migratory route during the first 24 hr postinjection (Fig. 4B) .
The Journal of Neuroscience, July 1993. 13(7) 2935 at the anterior extent of the migratory route adjacent to the granule cell layer (Fig. 4B) . Note, however, that relatively few cells had entered the granule cell layer and that none of the 3H-Thy-labeled cells detected at this time were immunoreactive for NSE (Table 2 , Fig. 5C ). These data clearly show that RBand cdc2-IR decrease prior to full neuronal differentiation. By 4 weeks postinjection, the majority (87%) of >H-Thy-labeled cells detected were located in the internal granular layer (Fig.  4B) , none of which showed intense RB-IR staining and 40.1% of which were now immunoreactive for NSE (Table 2 , Fig. 5D ).
Discussion
The data demonstrate that RB-and cdc2-IR can be expressed both by proliferating and by nonproliferating cells in the adult brain. RB in particular was expressed throughout the brain, with very intense nuclear RB-IR staining observed in hippocampal pyramidal cells, cerebellar Purkinje cells, and pyriform cortex, as well as in neuroblasts located in the hippocampal formation and olfactory bulb. CdQ-IR was much less ubiquitous and was detected in cerebellar Purkinje cells, olfactory bulb mitral cells, some hilar cells, and in some thymidine-labeled precursor cells. The data also indicate that the expression of RB and cdc2 changes dramatically as cells mature and differentiate into neurons. In particular, the number of thymidine-labeled cells expressing RBor cdc2-IR decreased substantially to virtually undetectable levels within 1 week after thymidine injection. As cells matured, cdc2 continued to be undetectable whereas RB-IR increased to low but detectable levels comparable to the levels observed in adjacent granule cells.
The fact that only 32.5% and 30.4% of the thymidine-incorporating cells detected in the dentate gyrus and olfactory bulb, respectively, 2 hr postinjection displayed cdQ-IR suggests that cdc2 expression is not constant throughout the cell cycle and is not highly correlated with S-phase in these cells. This is consistent with recent findings that suggest that, in mammalian cells, one of several cdc2-related kinases, most notably the ~33~~~*, can functionally replace cdc2 during the G, to S transition (Elledge and Spottswood, 199 l) , possibly restricting cdc2's role in these cells to the G, to M transition and the commitment to divide (Tsai et al., 199 1; Hamaguchi et al., 1992; Pagan0 et al., 1992) . Since the antibody used in this study does not cross-react with cdk2 (Riabowol et al., 1989 ) the possibility that cdk2 or some other cdc2-related kinase is expressed in the nucleus of these cells during S-phase cannot be excluded.
A close correspondence was observed between the number of 3H-Thy/RB-labeled cells detected 2 hr postinjection in the subgranular region of the dentate gyrus (80.5%) and the number of 3H-Thy/NSE-labeled cells detected in the dentate granule cell layer 4 weeks later (82.0%) suggesting that most, if not all, of In contrast, only 19.7% of the jH-Thy-labeled cells detected in the CA4 region of the dentate gyrus 2 hr postinjection showed intense nuclear RB-IR staining. Previous studies have identified small numbers of neuronal precursor cells located in CA4 that are thought to migrate to the subgranular region of the dentate gyrus (Bayer, 1982; Gu6neau et al., 1982; Altman and Bayer, 1990) . It has been suggested that the remaining thymidine-labeled cells in CA4 (the majority) represent a separate precursor population that remains in CA4 and gives rise to glia (GuCneau et al., 1982) . Alternatively, these cells may constitute a pool of proliferating stem cells that migrate to the subgranular region and become "dividing transit cells" as defined by Potten and Loeffler (1990) . In the present study, all 3H-Thy-labeled cells detected in CA4 at 4 weeks postinjection were NSE negative.
Likewise, of the small number of thymidineincorporating cells detected elsewhere in the brain including the striatum, thalamus, and cortex, fewer than 10% displayed intense, nuclear RB-IR staining or were immunoreactive for NSE at any of the time points examined.
Consequently, there appears to be a good correlation in these structures between intense nuclear RB-IR staining during S-phase and subsequent neuronal differentiation.
Other evidence that RB plays a role during cellular differentiation has been reported. A correlation was recently observed between RB-IR staining and cellular differentiation/maturation in embryonic SCID mouse tissues (Szekely et al., 1992) . Yen et al. (1992) have reported that terminal differentiation of HL-60 cells (a human promyelocytic leukemia cell line) is preceded by a reduction in the cellular content of RB, with failure to differentiate correlated with an insufficient reduction of RB. Likewise, a correlation between the inactivation of RB and the pathogenesis of lung tumors expressing neuronal or neuroendocrine phenotypes has been reported (Harbour et al., 1988) . Evidence that RB plays a critical role during neuronal differentiation is also supported by recent findings showing that transgenic mice that lack a functional RB gene display severe CNS pathology and ectopic mitoses beginning in middle (embryonic days 10-l l), but not early, embryonic development (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) .
The function of RB in adult, differentiated CNS neurons is currently unclear.
Many mitogenic growth factors, including epidermal growth factor, fibroblast growth factor, and insulinlike growth factors, are present in brain. One possibility is that constitutive expression of RB by CNS neurons is necessary to prevent growth factors from stimulating differentiated CNS neurons to divide. Another possibility is that RB actively regulates transcriptional activity associated with neuronal function. Many studies point to RB as a regulator of transcriptional activity via binding to intracellular factors such as E2F, c-myc, N-myc, and Fos (Bagchi et al., 199 1; Bandara and La Thangue, 199 1; Bandara et al., 1991; Chellappan et al., 1991; Defeo-Jones et al., 199 1; Kaelin et al., 199 1; Rustgi et al., 199 1) . In particular, the ability for the underphosphorylated form of RB to bind and sequester the transcription factor E2F has been strongly correlated with RB's ability to inhibit cell cycle progression (Bandara and La Thangue, 199 1; Bandara et al., 199 1; Chellappan et al., 199 1; Chittenden et al., 199 1) . One recent study detected high levels of E2F mRNA in the adult brain relative to other tissues (Helin et al., 1992) . The specific cells expressing E2F have not yet been identified; however, one possibility is that RB serves to regulate E2F activity in adult CNS neurons. RB can also bind directly with DNA (Lee et al., 1987; Wang et al., 1990) and has been shown to regulate transcription from a variety of promoters including c-fos, c-myc, transforming growth factor @l and insulin-like growth factor II (Pietenpol et al., 1990; Robbins et al., 1990; Kim et al., 1991 Kim et al., , 1992 . Most of these factors have been detected in the adult and developing CNS, where they have been postulated to play an important role in the transduction of extracellular signals associated with neural activation, synaptic plasticity, and growth (Adamson, 1987; Sudol, 1988) . RB has also been shown to repress c-fis expression and AP-1 transcriptional activity in 3T3 cells (Robbins et al., 1990) . Likewise, RB may regulate APl activity in neurons. We find it noteworthy that neurons that stained most intensely for RB-IR (i.e., CA1 pyramidal cells, pyriform cortex, and cerebellar Purkinje cells) have been demonstrated to be highly susceptible to neuronal loss following ischemia (Pulsinelli et al., 1982; Smith et al., 1984) . Yen and coworkers have recently proposed that RB serves as a "status quo" gene whose function is to sustain a "developmentally ordained" state of proliferation or differentiation and that a change in RB expression indicates a change in the developmental or functional state of the cell (Yen et al,, 199 1, 1992) . The possibility that RB may be serving a similar function in brain is intriguing and merits further study.
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